Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment.
Liang-Kung Chen, Jean Woo, Prasert Assantachai...
https://pubmed.ncbi.nlm.nih.gov/32033882/Actively Recruiting
Led by Zhejiang Provincial People's Hospital · Updated on 2024-08-05
450
Participants Needed
5
Research Sites
52 weeks
Total Duration
Researchers are conducting a multicenter, single-blind, randomized controlled trial to evaluate the safety and effectiveness of combined interventions for sarcopenia, a condition characterized by loss of muscle mass and strength. Participants who meet the diagnostic criteria for sarcopenia and are 30 years or older are included. The trial compares routine interventions alone and in combination with supplements to assess their impact on muscle health and physical function. Participants are divided into three groups a control group receiving routine care including nutritional guidance, progressive resistance exercise, safety advice, and treatment for complications over 24 weeks an experimental group 1 receiving the same routine care plus whey protein powder supplementation for 12 weeks at 60 grams per day in three doses and an experimental group 2 receiving routine care along with both whey protein powder and eldecalcitol capsules at 0.75 micrograms daily for 12 weeks. Liver and kidney function are monitored to adjust protein dosage if needed. Throughout the 24-week study, participants undergo regular assessments including general health evaluations, blood tests, muscle mass and strength measurements, and physical function tests like grip strength and 6-meter walking speed. Researchers also monitor adverse events to evaluate safety. The main outcome is muscle mass change, with secondary outcomes including muscle strength, walking speed, and incidence of adverse reactions.
CONDITIONS
Clinical Intervention of Idecalcitol Combined With Whey Protein Powder and Exercise for Sarcopenia
J
Jianfeng Tu, Doctor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Zhejiang Provincial People's Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 24 weeks
Participants undergo a comprehensive intervention including progressive resistance exercise, nutritional guidance, and symptomatic treatment. Some participants receive additional supplementation with whey protein powder and/or eldecalcitol for 12 weeks.
Regular visits as part of intervention and monitoring
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Liang-Kung Chen, Jean Woo, Prasert Assantachai...
https://pubmed.ncbi.nlm.nih.gov/32033882/Alfonso J Cruz-Jentoft, Avan A Sayer
https://pubmed.ncbi.nlm.nih.gov/31171417/Kazushige Maeda, Junya Imatani, Shiro Moritani...
https://pubmed.ncbi.nlm.nih.gov/33349543/Zhejiang Provincial People's Hospital
Lead Sponsor